{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:6212",
      "entity_text" : "CF",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03783",
      "entity_text" : "PTC124",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "To date, PTC124 has been tested preclinically in diverse models of nonsense mediated disease, including CF, Miyoshi myopathy, Hurler syndrome, Carnitine palmitoyltransferase 1A deficiency, Usher syndrome and Batten disease.",
  "reading_complete" : "2020-08-03T16:10:43Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:09:15Z",
  "trigger" : "mediated",
  "evidence" : [ "PTC124 has been tested preclinically in diverse models of nonsense-mediated disease, including CF" ],
  "pmc_id" : "4094583",
  "score" : 0
}